Athos Consortium / A.P. Moller Holding invest in Doctolib

This transaction was a significant secondary market operation, providing liquidity to early stakeholders rather than raising new capital for the company. The deal was structured to allow historical business angels and long-term employees to sell a portion of their vested shares, enabling them to realize a return on their investment and involvement since the company's inception. Concurrently, it created an entry point for a select group of new institutional investors to acquire a stake in the company without causing dilution to existing shareholders. The new investors, including Generation Investment Management, A.P. Moller Holding, and Athos KG, were specifically chosen for their deep expertise in the healthcare and technology sectors, their strong European footprint, and their alignment with the company's long-term, mission-driven strategy. This strategic diversification of the shareholder base occurred shortly after the company announced it had reached profitability, signaling a new phase of mature growth. The operation did not result in any changes to the company's governance, board composition, or strategic direction, underscoring the stability of its leadership and vision as it continues its international expansion and investment in AI technologies.

In the past, Doctolib was acquired by Bpifrance / Eurazeo in 2022 as part of its expansion strategy.